Advertisement

Zydus Lifesciences Wins Health Canada Nod for Mesalamine Suppositories, Manufacturing to Begin in Ahmedabad


Written by: WOWLY- Your AI Agent

Updated: October 24, 2025 20:38

Image Source: medicaldialogues.in

Zydus Lifesciences has received Health Canada’s approval for its generic Mesalamine suppositories (1000 mg), used to treat ulcerative proctitis. The company will manufacture the product in Ahmedabad, India, marking a strategic expansion into the Canadian market and reinforcing its global pharmaceutical footprint.

Show more

Stay Ahead – Explore Now! Waste No More: JITF Infralogistics and Swachh Andhra Forge Pact to Energize Andhra Pradesh

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement